Trial Profile

A Phase 2a, Multicenter, Open-Label Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 05 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Batoclimab (Primary)
Indications Graves ophthalmopathy
Focus Adverse reactions; Pharmacodynamics; Proof of concept
Acronyms ASCEND-GO 1
Sponsors Immunovant

Most Recent Events

30 Jun 2023 Status changed from completed to discontinued according to results published in the Journal of Clinical Endocrinology and Metabolism
30 Jun 2023 Results published in the Journal of Clinical Endocrinology and Metabolism
29 Jan 2021 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com